• Molecular NamePhensuximide
  • Synonym(+/-)-N-Methyl-2-phenylsuccinimide; 1-Methyl-3-Phenylsuccinimide; Epimid; Fenosuccimide; Fensuccimide [DCIT]; Fensuximida [INN-Spanish]; Lifene; Methylphenylsuccinimide; Milontin; Milontin (TN); Milonton; Mirontin; Mirotin;7 Phenosuccimide; N-Methyl-2-phenylsuccinimide; N-Methyl-alpha-phenolsuccinimide; N-Methyl-alpha-phenylsuccinimide; Phensuximid; Phensuximide (USP); Phensuximide [BAN:INN]; Phensuximidum [INN-Latin]; Phenylsuximide; Succinimide, N-methyl-2-phenyl-; Succitimal
  • Weight189.214
  • Drugbank_IDDB00832
  • ACS_NO86-34-0
  • Show 3D model
  • LogP (experiment)1.079
  • LogP (predicted, AB/LogP v2.0)1.68
  • pkaN/A
  • LogD (pH=7, predicted)1.68
  • Solubility (experiment)7.02 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-1.9
  • LogSw (predicted, AB/LogsW2.0)2.53
  • Sw (mg/ml) (predicted, ACD/Labs)2.36
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds1
  • TPSA37.38
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anticonvulsant in the succinimide class.
  • Absorption_value100.0
  • Absorption (description)Rapid and complete
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding21.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life8 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A